U
RDY icon

UBS’s Dr. Reddy's Laboratories RDY Stock Holding History

UBS’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$5.11M Sell
486,100
-89,050
-15% -$837K ﹤0.01% 2008
2014
Q2 		$4.96M Sell
575,150
-54,630
-9% -$459K ﹤0.01% 1978
2014
Q1 		$5.53M Buy
629,780
+87,705
+16% +$763K ﹤0.01% 1769
2013
Q4 		$4.45M Buy
542,075
+840
+0.2% +$6.65K ﹤0.01% 1984
2013
Q3 		$4.09M Buy
541,235
+151,160
+39% +$1.1M ﹤0.01% 1878
2013
Q2 		$2.95M Buy
+390,075
New +$2.85M ﹤0.01% 2120

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

UBS's RDY Position: Q3 2014 in Review

UBS reduced its Dr. Reddy's Laboratories (RDY) stake by 15% in Q3 2014, selling an estimated $837K and leaving 486,100 shares worth $5.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2008.

UBS first reported a position in RDY in Q2 2013 and has held it in 6 quarters since. The position peaked at $5.53M in Q1 2014. 159 funds tracked by Wall St. Rank hold RDY as of Q3 2014.

  • UBS held 486,100 shares of Dr. Reddy's Laboratories worth $5.11M as of Q3 2014.
  • UBS sold 89,050 Dr. Reddy's Laboratories shares in Q3 2014, an estimated $837K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2008 holding.
  • UBS first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 6 quarters since.
  • UBS's Dr. Reddy's Laboratories position peaked at $5.53M in Q1 2014.
  • 159 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.